| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRSL.2007.12.004 |
| P698 | PubMed publication ID | 18355769 |
| P2093 | author name string | Wu-Hsien Kuo | |
| Horng-Rong Chang | |||
| Shun-Fa Yang | |||
| Shu-Chen Chu | |||
| Yih-Shou Hsieh | |||
| Jong-Da Lian | |||
| Chiu-Chu Lin | |||
| Mei-Lan Lee | |||
| P2860 | cites work | Cystatin C as a marker of GFR--history, indications, and future research | Q28298855 |
| Chronic renal allograft rejection: pathophysiologic considerations | Q34426267 | ||
| Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis | Q34625149 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Kidney transplantation: the evolving challenges | Q35887750 | ||
| Proteinases and glomerular matrix turnover | Q36058205 | ||
| Chronic renal allograft dysfunction | Q36240051 | ||
| Role of matrix metalloproteinases in renal pathophysiologies | Q36693229 | ||
| Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy | Q37352123 | ||
| Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. | Q40450574 | ||
| Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes | Q40712590 | ||
| The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells | Q41893212 | ||
| Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis | Q44625408 | ||
| Increased cystatin C serum concentrations in patients with hepatic diseases of various severities | Q44766564 | ||
| Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury | Q46073081 | ||
| Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats | Q46399145 | ||
| Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease | Q46594478 | ||
| Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease | Q46824587 | ||
| Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer | Q47343540 | ||
| Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). | Q50484217 | ||
| Neutral proteinase activity produced in vitro by cells of the glomerular mesangium | Q70431332 | ||
| Quantitative zymography: detection of picogram quantities of gelatinases | Q72158755 | ||
| Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy | Q73235853 | ||
| Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? | Q73480141 | ||
| Significant differences in serum activities of matrix metalloproteinase-2 and -9 between HCV- and HBV-infected patients and carriers | Q73571853 | ||
| Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM | Q74110831 | ||
| The clinical significance of gelatinase B in gouty arthritis of the knee | Q75196829 | ||
| Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors | Q77070059 | ||
| Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy | Q77291539 | ||
| Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels | Q78425861 | ||
| Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes | Q80349976 | ||
| Evolution and pathophysiology of renal-transplant glomerulosclerosis | Q80465077 | ||
| Fibrosis and matrix metalloproteinases in rat renal allografts | Q81631409 | ||
| Markers of fibrosis in early biopsies of renal transplants | Q81706971 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 217-223 | |
| P577 | publication date | 2008-01-28 | |
| P1433 | published in | Translational Research | Q15761127 |
| P1476 | title | Circulating matrix metalloproteinase-2 is associated with cystatin C level, posttransplant duration, and diabetes mellitus in kidney transplant recipients | |
| P478 | volume | 151 |
| Q33829301 | LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells |
| Q27004621 | Matrix metalloproteinases in kidney homeostasis and diseases |
| Q38203501 | Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis |
Search more.